Teladoc Health Reports First Quarter 2026 Results
Teladoc reported Q1 2026 revenue of $613.8 million, a 2% decrease from the prior year, with a net loss of $63.8 million or $0.36 per share. Adjusted EBITDA came in at $58.2 million, flat year-over-year and exceeding the midpoint of the company's guidance range.
Key figures
- Revenue
- $613.8 million
- Guidance
- FY26 revenue $2,481 - $2,576 million; Adjusted EBITDA $267 - $306 million
AI analysis
Red flags2 · Pro
The rest of the AI analysis, red flags and sentiment are part of Signal8 Pro.
AI-generated analysis of a public disclosure. Not investment advice; verify against the original document.